Terminally ill gymnast Sonny Lang has the 'heart and lungs of an 80-year-old'
Sonny Lang, 22, from Tadcaster, North Yorkshire, has cystic fibrosis, but has been told her body is too weak for another heart and lung transplant, so her prognosis is terminal.
Conclusions: Patients with CF after LT have a reduced maximal exercise capacity without ventilatory or cardiac limitations that persists despite the rehabilitative activity. Our findings showing a low work "efficiency" (low work/VO2 slope) suggest that the reduced exercise capacity could be attributable to muscle-related abnormality in oxygen metabolism in peripheral muscle
Introduction: The presence of pulmonary hypertension (PH) before lung transplantation (LuTx) is a well known risk factor for primary graft dysfunction (PGD). However, the role of the comprehensive cardiopulmonary hemodynamic assessed before LuTx is limited. We aimed to explore if other hemodynamic variables may have a role in PGD, besides absolute PH.Methods: a retrospective study was conducted at Policlinico Hospital of Milan (Italy) on adults who underwent LuTx for any indication other than cystic fibrosis from 2011 to 2017. PGD was defined as PaO2/FIO2
Authors: Hsin MKY, Wong CF, Yan SW, Fan KY, Ho CKL, Bhatia I, Au TWK Abstract Clinical lung transplant was first performed in Hong Kong in 1995. In the early years, the volume of activity was very low. There has been a clear trend of increasing volume in the past few years. The recipient pathology is very different from the International Society for Heart and Lung Transplantation (ISHLT) database, with complete absence of cystic fibrosis and alpha-1-antitrypsin deficiency, and a predominance of diseases of the pulmonary circulation. Lymphangioleiomyomatosis (LAM) has a much higher representation on the waiting list...
Claire Wineland vowed she wouldn't have a lung transplant, but her decline from cystic fibrosis made her reconsider. Now she's fighting for a chance at survival.
In this study we investigated regulatory t cells after combined lung and liver transplantation, or after isolated lung transplantation, in cystic fibrosis patients and correlated the findings with long term outcomes
Patients with cystic fibrosis (CF) may have pulmonary infection with multi-drug resistant organisms (MDRO) potentially impacting post-transplant mortality. Our objective was to study 1-year mortality in CF patients with MDRO compared to those without MDRO lung transplant recipients (LTR) querying the largest international registry.
Early detection of Mycobacterium abscessus complex (MABSC) is crucial for patients with chronic lung disease to enhance the opportunity for potential eradication. Colonisation with MABSC is an absolute contra indication to lung transplantation in many transplant centres. Isolation of MABSC and other non-tuberculous mycobacteria (NTM) by traditional AFB culture is problematic, particularly from patients with cystic fibrosis (CF). Cultures are frequently overgrown by other bacteria or fungi and sputum decontamination procedures can reduce the viability of NTM.
Lobar lung transplantation is known as an alternative for higher Donor/Receiver mismatch in cystic fibrosis or idiopathic pulmonary fibrosis patients. Using lobar lung transplantation for Pulmonary Hypertension remains questionable because of the higher risk of primary graft dysfunction. We thought to determine wether lobar lung transplantation from brain-dead donors is an option for Pulmonary Hypertension.
This study aims to characterize this acute airway inflammation in association with ACR status.